New Molecules Boost Cancer Immunotherapy and Target Stubborn Tumors
Researchers in Basel and Cambridge have engineered small molecules known as Phagocytic Synapse Enhancers (PSEs) that bridge the gap between stubborn solid tumors and immune system macrophages. Published in the ... Read More